| Diffuse Large B-Cell Lymphoma |
1 |
1 |
| Biologic Therapy |
0 |
0.95 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.9 |
| CAR-T |
0 |
0.68 |
| Chemotherapy |
0 |
0.99 |
| B-Cell Lymphoma |
0 |
0.38 |
| Antineoplastic Drug |
0 |
0.35 |
| Primary Mediastinal B-Cell Lymphoma |
0 |
0.34 |
| Lymphoma |
0 |
0.3 |
| Stem Cell Research and Therapy |
0 |
0.29 |
| Monoclonal Antibody |
0 |
0.25 |
| Remission |
0 |
0.25 |
| Transplantation |
0 |
0.25 |
| Toxicology |
0 |
0.24 |
| Autologous stem cell transplant |
0 |
0.21 |
| Refractory |
0 |
0.2 |
| COVID-19 |
0 |
0.16 |
| Cancer |
0 |
0.15 |
| Leukemia |
0 |
0.14 |
| Immunotherapy |
0 |
0.1 |
| Massachusetts |
0 |
0.1 |